Download Summary
Norway is among the highest scoring in terms of Policy Context. This is due to a comprehensive asthma strategy, severe asthma guidelines, and Norway’s reporting to severe asthma registries. Limited alignment of national guidelines with international best practices and comparatively modest tobacco control laws limit Norway’s ability to score higher in this category. In terms of Access and Care Coverage, Norway ranks close to average. While Norway shows relatively low unmet needs and high levels of access to biologics-based treatment, specialist care, and diagnostics such as inflammatory phenotyping, improvement could be made in access to other treatments, digital therapeutics, and FeNO-based diagnosis. Norway has among the lowest Disease Burden scores, which is attributable to one of the highest estimated societal costs of asthma and the number of DALYs attributable to asthma. Having some of the lowest rates of adult tobacco use improves Norway’s score in this category.
Data from the Severe Asthma Index revealed the following key insights about severe asthma care in Norway
Provides further insights into how Norway scores across each Index category
Guidelines, strategies, and policies related to the management of severe asthma and health outcomes
86/100
Regulations and practices concerning public payor coverage for and availability of diagnostic and treatment services for severe asthma
64/100
Indicators related to clinical management and economic impact of severe asthma and recording of patient health data
47/100
Information about the health impact of severe asthma and severe asthma comorbidities
62/100
Factors impacting prevention, management, and exacerbations of severe asthma
75/100
Aggregate score across the 5 categories.
68.2/100
Explore how each of the 29 OECD countries scored in the Severe Asthma Index
Select different countries to see how they scored across each of the 5 categories and overall